In another study, minocycline delayed disease progression in a R6/2 mouse model of HD by inhibiting caspase-1 and caspase-3 mRNA upregulation and decreasing inducible nitric oxide synthetase activity [42]. This evidence concerns the gene CASP1 and Huntington disease.